CINECA IRIS Institutional Research Information System

GASCO, Valentina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.761
AS - Asia 3.892
EU - Europa 3.098
SA - Sud America 615
AF - Africa 104
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.503
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.618
SG - Singapore 1.658
CN - Cina 945
IT - Italia 858
BR - Brasile 454
VN - Vietnam 358
DE - Germania 347
SE - Svezia 336
IE - Irlanda 309
FR - Francia 273
FI - Finlandia 220
KR - Corea 207
JP - Giappone 168
UA - Ucraina 161
GB - Regno Unito 151
HK - Hong Kong 111
IN - India 111
PL - Polonia 88
CA - Canada 73
ES - Italia 60
MX - Messico 56
AR - Argentina 54
RU - Federazione Russa 46
NL - Olanda 43
TR - Turchia 42
AT - Austria 40
CO - Colombia 40
BD - Bangladesh 36
IQ - Iraq 33
PH - Filippine 31
BE - Belgio 30
GR - Grecia 28
ID - Indonesia 27
AU - Australia 24
UZ - Uzbekistan 24
SA - Arabia Saudita 23
ZA - Sudafrica 21
CH - Svizzera 19
CL - Cile 17
DZ - Algeria 17
EC - Ecuador 14
EG - Egitto 14
PK - Pakistan 13
RO - Romania 13
OM - Oman 12
PT - Portogallo 12
IL - Israele 10
LT - Lituania 10
PE - Perù 10
TH - Thailandia 10
VE - Venezuela 10
JO - Giordania 9
MA - Marocco 9
TW - Taiwan 9
CZ - Repubblica Ceca 8
IR - Iran 8
KE - Kenya 8
MY - Malesia 8
PY - Paraguay 7
RS - Serbia 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
HR - Croazia 6
UY - Uruguay 6
CR - Costa Rica 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
BT - Bhutan 4
ET - Etiopia 4
HU - Ungheria 4
JM - Giamaica 4
SI - Slovenia 4
SN - Senegal 4
AZ - Azerbaigian 3
BO - Bolivia 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
CY - Cipro 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LB - Libano 3
LV - Lettonia 3
MU - Mauritius 3
NP - Nepal 3
BG - Bulgaria 2
BN - Brunei Darussalam 2
DK - Danimarca 2
EU - Europa 2
KH - Cambogia 2
KW - Kuwait 2
NG - Nigeria 2
PA - Panama 2
PS - Palestinian Territory 2
AO - Angola 1
AP - ???statistics.table.value.countryCode.AP??? 1
CG - Congo 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
GA - Gabon 1
Totale 13.485
Salva come PNG Salva come JPEG
Città #
Singapore 919
Chandler 606
San Jose 550
Ashburn 474
Beijing 445
Santa Clara 415
Dublin 302
Houston 237
Ann Arbor 149
Turin 146
Nyköping 121
Seoul 120
Ho Chi Minh City 113
The Dalles 113
Hefei 112
Medford 112
Columbus 106
Lauterbourg 102
Fairfield 99
Los Angeles 94
Munich 94
Milan 92
Princeton 91
Redwood City 87
Hong Kong 86
Torino 82
Dearborn 80
Jacksonville 79
Wilmington 78
Buffalo 77
Tokyo 70
Hanoi 68
Warsaw 66
Dallas 64
Helsinki 61
Turku 59
Villeurbanne 59
Woodbridge 55
São Paulo 51
New York 47
Seattle 44
Rome 43
Boardman 38
Boston 37
Cambridge 37
Bengaluru 35
Guangzhou 35
Hangzhou 29
Redondo Beach 29
Brussels 28
London 28
Vienna 28
Orem 27
Frankfurt am Main 25
Chicago 22
Dong Ket 22
Mexico City 22
Toronto 22
Fremont 20
Jakarta 17
Chennai 16
Philadelphia 16
Pisa 16
Verona 16
Council Bluffs 15
Montreal 15
Nuremberg 15
Rio de Janeiro 15
Brooklyn 14
Atlanta 13
Barcelona 13
Haiphong 13
Hebei 13
Istanbul 13
Jeddah 13
Kunming 13
Shanghai 13
Stockholm 13
Amsterdam 12
Athens 12
Belo Horizonte 12
Bogotá 12
Buenos Aires 12
Mexico 12
Moscow 12
Phoenix 12
Santiago 12
Ankara 11
Campinas 11
Da Nang 11
Detroit 11
Florence 11
Lappeenranta 11
Madrid 11
Mountain View 11
Mumbai 11
Norwalk 11
Johannesburg 10
Munro 10
Muscat 10
Totale 7.872
Salva come PNG Salva come JPEG
Nome #
Management of GH treatment in adult GH deficiency 1.449
HLA DRB1*0415: a new possible genetic susceptibility factor for Hirata's disease 301
Involvement of hypothalamus autoimmunity in patients with autoimmune hypopituitarism: role of antibodies to hypothalamic cells. 285
Acylated ghrelin as a provocative test for the diagnosis of GH deficiency in adults. 282
USEFULNESS OF AN AD HOC QUESTIONNAIRE (ACRO-CQ) FOR THE SYSTEMATIC ASSESSMENT OF ACROMEGALY COMORBIDITIES AT DIAGNOSIS AND THEIR MANAGEMENT AT FOLLOW-UP 227
Traumatic Brain Injury as Frequent Cause of Hypopituitarism and Growth Hormone Deficiency: Epidemiology, Diagnosis, and Treatment 181
L'ipopituitarismo post trauma cranico: dall'età pediatrica all'età adulta 173
Long term safety of recombinant human growth hormone (rhGH) in patients treated during childhood 170
First but not second postoperative day growth hormone assessments as early predictive tests for long-term acromegaly persistence 160
Development and internal validation of a predictive model for the estimation of pheochromocytoma recurrence risk after radical surgery 151
Progression of pituitary tumours: impact of GH secretory status and long-term GH replacement therapy 150
From SGAP-Model to SGAP-Score: A Simplified Predictive Tool for Post-Surgical Recurrence of Pheochromocytoma 144
Pituitary-gonadal function in males with Down’s syndrome. 143
Cortistatin-17 and somatostatin-14 display the same effects on growth hormone, prolactin, and insulin secretion in patients with acromegaly or prolactinoma 141
Acylated ghrelin as provocative test for the diagnosis of ACTH deficiency in patients with hypothalamus–pituitary disease 137
Endocrine and metabolic actions of ghrelin 137
SENSITIVITY AND SPECIFICITY OF DIFFERENT PROVOCATIVE TESTS ASSESSING THE FUNCTION OF HYPOTHALAMO-PITUITARY-ADRENAL (HPA) AXIS IN PATIENTS SUSPECTED FOR SECONDARY HYPOADRENALISM 135
Use of the Diabetes Risk Score for Opportunistic Screening of Undiagnosed Diabetes and Impaired Glucose Tolerance: The IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study 135
Association of Urine Metanephrine Levels with Cardiometabolic Risk: An Observational Retrospective Study 134
Treatment of acromegaly with SS analogues: should GH and IGF-I target levels be lowered to assert a tight control of the disease? 132
Cut-off limits of the GH response to GHRH plus arginine test and IGF-I levels for the diagnosis of GH deficiency in late adolescents and young adults. 129
Acromegalia e gravidanza: quali rischi per la madre e per il feto 129
Copeptin adaptive response to SGLT2 inhibitors in patients with type 2 diabetes mellitus: The GliRACo study 128
Early copeptin determination allows prompt diagnosis of post-neurosurgical central diabetes insipidus 128
Association of craniopharyngioma and pituitary adenoma. 126
Growth hormone levels in the diagnosis of growth hormone deficiency in adulthood. 126
Untreated adult GH deficiency is not associated with the development of metabolic risk factors: a long-term observational study 125
Retrospective observational analysis of non-irradiated non-functioning pituitary adenomas 124
Acromegaly and joint pain: is there something more? A cross-sectional study to evaluate rheumatic disorders in growth hormone secreting tumor patients 124
Neuroendocrine response to diclofenac in healthy subjects: a pilot study 123
Measurement of height velocity is an useful marker for monitoring pituitary function in patients who had traumatic brain injury 123
Effects of chronic slow release-lanreotide treatment on insulin-like growth factor system and metabolic parameters in acromegalic patients 122
Hypopituitaric patients with corticotropin insufficiency show marked impairment of the cortisol response to ACTH (1-24) independently of the duration of the disease. 122
MORNING SERUM CORTISOL LEVEL PREDICTS CENTRAL ADRENAL INSUFFICIENCY DIAGNOSED BY INSULIN TOLERANCE TEST 122
COMPARISON BETWEEN ITT, METYRAPONE AND ACTH STIMULATION WITH HIGH, LOW AND VERY LOW DOSES FOR DIAGNOSIS OF SECONDARY HYPOADRENALISM 121
Development and Internal Validation of a Predictive Model for Adult GH Deficiency Prior to Stimulation Tests 121
Update on epidemiology, etiology, and diagnosis of adult growth hormone deficiency 120
Diagnostica neuroendocrina del paziente obeso (alterazioni neuroendocrine nel paziente obeso) 119
Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment 119
Growth hormone/insulin-like growth factor I axis, glucose metabolism, and lypolisis but not leptin show some degree of refractoriness to short-term fasting in acromegaly 119
Diagnosis of adult GH deficiency 118
Normal age-dependent values of serum insulin growth factor-I: results from a healthy Italian population 118
THE CUT-OFF LIMITS OF GH RESPONSE TO INSULIN TOLERANCE TEST RELATED TO BODY MASS INDEX FOR THE DIAGNOSIS OF ADULT GH DEFICIENCY 118
L-Arginine 116
Cost-of-illness study in acromegalic patients in Italy. 114
Development and internal validation of a predictive score for the diagnosis of central adrenal insufficiency when morning cortisol is in the grey zone 112
The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index 111
Hypopituitarism following brain injury: when does it occur and how best to test? 111
Primary pituitary lymphoma as rare cause of a pituitary mass and hypopituitarism in adulthood 111
Second-Day Morning Cortisol Levels after Transsphenoidal Surgery Are Accurate Predictors of Secondary Adrenal Insufficiency with Diagnostic Cut-Offs Similar to Those in Non-Stressed Conditions 110
Central and peripheral regulation of the GH/IGF-1 axis: GHRH and beyond 108
Are prolactin levels efficient in predicting a pituitary lesion in patients with hyperprolactinemia? 108
Adrenocortical, somatotropic, and antidiuretic response to nasal glucagon in healthy subjects. 108
Diagnostic reliability of a single IGF-I measurement in 237 adults with total anterior hypopituitarism and severe GH deficiency. 108
ONCE UPON A TIME: THE GLUCAGON STIMULATION TEST IN DIAGNOSING ADULT GH DEFICIENCY 105
Benefits of dual-release hydrocortisone treatment on central adiposity and health-related quality of life in secondary adrenal insufficiency 104
Pegvisomant in acromegaly: why, when, how. 104
Ghrelin and anterior pituitary function 104
Ghrelin in the regulation of GH secretion and other pituitary hormones. 103
Three-hour spontaneous GH secretion profile is as reliable as oral glucose tolerance test for the diThree-hour spontaneous GH secretion profile is as reliable as oral glucose tolerance test for the diagnosis of acromegaly. 102
Appropriate management of growth hormone deficiency during the age of transition: an Italian Delphi consensus statement 101
First-line therapy of acromegaly: a statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous medical Education) Study Group. 99
Replacement therapy in adult with GHD: how to treat and monitor. 98
Long-term safety and efficacy of Omnitrope® in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults study 98
Retesting the childhood-onset GH-deficient patient 97
Functioning and non-functioning pituitary adenomas in 173 adult and elderly patients 96
A 2024 Update on Growth Hormone Deficiency Syndrome in Adults: From Guidelines to Real Life. 93
Psychiatric disorders and anger in patients with controlled acromegaly 92
Optimal timing of blood samplings to detect GH inhibition during oral glucose tolerance test 92
Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center 91
Hormonal diagnosis of GH hypersecretory states. 91
Metabolic alterations in patients who develop traumatic brain injury (TBI)-induced hypopituitarism 91
Relationship of CYP21A2 genotype and serum 17-hydroxyprogesterone and cortisol levels in a large cohort of Italian children with premature pubarche 90
The manifesto A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) study group one year later: what to keep and what to amend? 90
Ruolo del surrene nelle varie fasi dello sviluppo puberale 88
Impatto socio economico dei trattamenti 88
Identifying Patients at Risk for Microalbuminuria via Interaction of the Components of the Metabolic Syndrome: A Cross-Sectional Analytic Study 88
Disordini dell'accrescimento e dello sviluppo puberale 87
GH but not IGF-I hypersecretion in acromegaly is generally attenuated in elderly acromegalics. 86
Hypopituitarism and growth hormone deficiency (GHD) after traumatic brain injury (TBI). 85
Microalbuminuria in insulin sensitivity in patients with growth hormone-secreting pituitary tumor 84
Trabecular Bone Score as an Index of Bone Fragility in Patients with Acromegaly: A Systematic Review and Meta-Analysis. 83
Sindrome della sella vuota 83
Growth hormone receptor variants and response to pegvisomant in monotherapy or in combination with somatostatin analogs in acromegalic patients: a multicenter study 83
GHRH + arginine test and body mass index: do we need to review diagnostic criteria for GH deficiency? 82
Malattie ipotalamo-ipofisarie: Ipopituitarismo 82
Evaluation of GH deficiency by GHRH+arginine test and IGF-I levels in a large population of young, middle-aged and elderly patients who had undergone neurosurgery for tumor masses in the hypothalamus-pituitary area. 80
Pituitary Hyperplasia Due to Longstanding Primary Hypothyroidism: A Case Report and Comprehensive Review of the Literature. 79
Mean GH profile is more accurate than single fasting GH in the evaluation of acromegaly disease control during somatostatin receptor ligands therapy 79
Isolated anterior pituitary dysfunction in adulthood 78
Excess mortality in patients with non-functioning pituitary adenoma: a systematic review and meta-analysis 77
Occurrence of GH deficiency in adult patients who underwent neurosurgery in the hypothalamus-pituitary area for non-functioning tumour masses. 76
An overview of the controversies of adult growth hormone deficiency diagnosis. 75
Premature Pubarche 75
Different degrees of GH deficiency evidenced by GHRH+arginine test and IGF-I levels in adults with pituritary disease 72
Efficacy and safety of 48 weeks of treatment with octreotide LAR in newly diagnosed acromegalic patients with macroadenomas: an open-label, multicenter, non-comparative study 72
Mild hyponatremia is not associated with degradation of trabecular bone microarchitecture despite bone mass loss. 69
MRI Assessment of Cardiac Function and Morphology in Adult Patients With Growth Hormone Deficiency: A Systematic Review and Meta-Analysis 68
Desmopressin dose requirements in patients with permanent arginine vasopressin deficiency: a tertiary center experience. 67
Evaluation of fluid status in patients with acromegaly through bioelectrical impedance vector analysis: a cross-sectional study 65
Totale 12.800
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.793
article - articoli 0
book - libri 0
conference - conferenze 1.757
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.550
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021127 0 0 0 0 0 0 0 0 0 0 0 127
2021/20221.104 50 53 71 60 94 48 54 71 56 93 227 227
2022/20231.690 176 141 28 185 171 375 124 88 181 55 107 59
2023/2024740 89 117 31 56 36 62 44 71 17 53 57 107
2024/20252.522 22 159 67 230 565 150 62 136 323 114 263 431
2025/20264.438 567 277 305 527 531 228 847 182 307 450 178 39
Totale 13.928